Larotrectinib Sulfate
ATC L01EX12 · 4 markets · 12 records
CA 3 records · 3 shown of 3
AU 3 records · 3 shown of 3
- 122.9 mgcapsuleVITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle
- 30.7 mgcapsuleVITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle
- 24.6 mg/mLliquidVITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle
SG 3 records · 3 shown of 3
- 100 mgcapsuleVITRAKVI HARD CAPSULE 100MG
- 25 mgcapsuleVITRAKVI HARD CAPSULE 100MG
- 20 mg/mLliquidVitrakvi 20mg/ml oral solution
FR 3 records · 3 shown of 3
- 100 mgcapsuleVITRAKVI 100 mg, gélule
- 25 mgcapsuleVITRAKVI 100 mg, gélule
- 20 mgliquidVITRAKVI 20 mg/mL, solution buvable
| Strength / form / release | CA | AU | SG | FR |
|---|---|---|---|---|
| 100 mg capsule | VITRAKVI | VITRAKVI HARD CAPSULE 100MG | VITRAKVI 100 mg, gélule | |
| 25 mg capsule | VITRAKVI | VITRAKVI HARD CAPSULE 100MG | VITRAKVI 100 mg, gélule | |
| 20 mg liquid | VITRAKVI | VITRAKVI 20 mg/mL, solution buvable | ||
| 122.9 mg capsule | VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle | |||
| 30.7 mg capsule | VITRAKVI larotrectinib (as sulfate) 25 mg hard capsule bottle | |||
| 24.6 mg/mL liquid | VITRAKVI larotrectinib (as sulfate) 20 mg/mL bottle | |||
| 20 mg/mL liquid | Vitrakvi 20mg/ml oral solution |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 SG 有記錄(未在本表顯示)。
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.